ClinicalTrials.gg
Not yet recruitingNCT06938191Updated Dec 1, 2025

Comparison of Aquaporin -4, -5, -9 and IL-8 Levels in GCF, Dentin Fluid and Pulp Samples

An observational study in Pulpitis, Pulpitis - Irreversible and Pulp Inflammation, sponsored by Kırıkkale University. Not yet recruiting. Open to participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-01.

Sponsored by Kırıkkale University · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2026, 9 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
70
Ages
18 Years to 64 Years
Sex
All
01

Study summary

This study aimed to compare the changes in AQP -4, -5, -9, and IL-8 levels in pulp tissue, GCF, and dentin fluid samples routinely obtained during the treatment of healthy and symptomatic teeth diagnosed with irreversible pulpitis and investigate whether there is a correlation between them.

A total of 70 patients aged 18-64 years with healthy (Group 1) and symptomatic irreversible pulpitis (Group 2) diagnosed at Kırıkkale University, Faculty of Dentistry, Department of Endodontics who will undergo routine root canal treatment will be included in the study, with a minimum of 35 participants for each group. Before starting treatment, DOS samples will be taken from healthy, symptomatic, irreversible pulpitis-diagnosed teeth and teeth contralateral to these teeth. A dentin fluid sample will be taken by holding the membrane on the dentin surface, and the pulp tissue will be removed and transferred to Eppendorf tubes. The treatment process will be completed by applying routine root canal procedures to the teeth. The samples' Aquaporin -4, -5, -9, and IL-8 levels will be analyzed by specific enzyme-linked immunosorbent assay (ELISA).

Read the detailed description

A total of 70 healthy (Group 1) and symptomatic irreversible pulpitis (Group 2) patients aged 18-64 years, who will undergo routine root canal treatment at Kırıkkale University, Faculty of Dentistry, Department of Endodontics, will be included in the study, with a minimum of 35 participants for each group. Before starting treatment, GCF samples will be taken from healthy, symptomatic, irreversible pulpitis-diagnosed teeth and teeth contralateral to these teeth. The tooth from which the GCF sample will be taken will be isolated with cotton pellets. After the supragingival plaque is carefully removed with a curette without touching the gums, the tooth will be dried with light air pressure for 10 seconds and periopaper strips will be placed in the gingival sulcus until resistance is felt. The periopaper strips will be removed from the gingival sulcus after 1 minute. While taking the samples, care should be taken not to contaminate with blood and saliva; contaminated samples will be repeated. The amount of GCF will be measured and recorded using the periotron device. The microliter equivalents of the values measured on the Periotron device will be recorded. Periopaper strips will be placed in 1.5 cc sterile eppendorf tubes. Gingival index and pocket depth measurements will be performed after GCF samples are taken to prevent irritation of periodontal tissues and blood contamination. Patients with a pocket depth of more than 4 mm will be excluded from the study.

After anesthesia with 1.8 ml articaine HCl containing 1:100000 epinephrine, the teeth will be isolated with rubber-dam disinfected with 70% alcohol. After disinfection of the tooth crowns and surrounding area with 30% hydrogen peroxide and 2.5% NaOCl, caries and existing restorations, if any, will be removed. In teeth with normal pulp, dentin fluid samples will be taken from the dentin cavity approximately 2 mm away from the pulp as calculated on radiographs. The exposed hard dentin surface will be dried with compressed air. Using a sterile press, 1 membrane per tooth will be applied to the exposed dentin for 1 minute and 1.5 mL will be transferred to a sterile eppendorf tube.

The pulp chamber ceiling will be removed with a No. 14 steel rond milling cutter using a micromotor. Using a sterile excavator and tirnerf, healthy and inflamed pulp samples will be removed and transferred to sterile eppendorf tubes to which 200 μl of Phosphate Buffer (PBS) pH:7.2 will be added.

While collecting the samples, care should be taken not to contaminate them with blood and saliva; GCF and dentin fluid samples with suspected contamination will be repeated. Patients with samples with contamination of pulp tissue or deterioration in storage conditions will be excluded from the study. GCF, dentin fluid and pulp tissue samples transferred to a 1.5 mL sterile eppendorf tube labeled with a code assigned to the patient with diagnosis and date, with low protein binding, kept immediately on ice, transferred to a freezer and kept at -20 °C. Samples will be transported from the clinic to the freezer at -80°C and stored in a freezer at -80°C to prevent denaturation until further analysis.

The treatment process will be completed by applying routine root canal procedures to the teeth. Teeth in the healthy pulp group with an indication for extraction will be extracted after the samples are taken, subjected to normal extraction procedures.

Aquaporin -4, -5, -9 and IL-8 levels of the samples will be analyzed by specific enzyme-linked immunosorbent assay (ELISA).

Data will be analyzed in computer environment with SPSS 28.0 (Statistical Package for the Social Sciences, NY, USA) statistical package program. Results will be evaluated at 95% confidence interval and p\<0.05 significance level.

02

Conditions studied

  • Pulpitis
  • Pulpitis - Irreversible
  • Pulp Inflammation
  • Healthy Pulp
  • Biomarkers

Browse trials for

Keywords

  • healthy pulp
  • pulpitis
  • irreversible pulpitis
  • aquaporin-4
  • IL-8
  • aquaporin-5
  • aquaporin-9
03

In context

Pulpitis

316 studies on the registry are indexed under Pulpitis; 90 are open to participants now.

This study's planned enrollment of 70 is close to the median of 75 across 23 observational studies indexed under Pulpitis.

Browse Pulpitis studies →

Lead sponsor

Kırıkkale University is the lead sponsor of 114 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

This study will include patients aged 18-64 years who present to the Department of Endodontics, Faculty of Dentistry, Kırıkkale University, with an indication for root canal therapy and are diagnosed with either a healthy pulp status (Group 1) or symptomatic irreversible pulpitis (Group 2).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 to 64 years.
  • Patients without any known systemic disease.
  • Patients requiring root canal treatment for prosthetic purposes (Healthy pulp group).
  • Patients with third molars (wisdom teeth) indicated for extraction due to orthodontic or other clinical reasons (Healthy pulp group).
  • Patients diagnosed with symptomatic irreversible pulpitis based on the criteria established by the American Association of Endodontists (AAE) (Symptomatic irreversible pulpitis group).
  • Patients scheduled for routine root canal treatment at the Department of Endodontics, Faculty of Dentistry, Kırıkkale University.
  • Patients who have provided written to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients with any known systemic disease.
  • Pregnant women or those suspected of being pregnant.
  • Patients who have used antibiotics, anti-inflammatory drugs, or antidepressants within the past 4 weeks.
  • Patients with significant dental plaque or calculus, gingival redness or bleeding, severe gingivitis, generalized periodontitis, or periodontal pockets deeper than 4 mm.
  • Patients with teeth showing internal or external root resorption.
  • Patients for whom complete rubber dam isolation cannot be achieved.
  • Patients with teeth exhibiting signs of necrosis, apical lesions, swelling, or presence of a sinus tract.
  • Patients with immature teeth presenting open apices.
  • Patients with third molars (wisdom teeth) that are not fully erupted or have been previously diagnosed with pericoronitis.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • healthy pulp group

    Minimum 35 participants Procedure: Collection of GCF samples using periopaper. Collection of dentinal fluid using cellulose membrane. Collection of pulp tissue samples using a tirnerf.

  • irreversible pulp group

    Minimum 35 participants Procedure: Collection of GCF samples using periopaper. Collection of dentinal fluid using cellulose membrane. Collection of pulp tissue samples using a tirnerf.

06

What researchers measure

Primary outcomes

  1. Aquaporin-4, Aquaporin-5 and Aquaporin-9 expression levels in pulp tissue in dentin fluid and GCF samples

    Levels of IL-8, AQP-4, AQP-5 and AQP-9 will be measured in dentin fluid, GCF and pulp tissue samples obtained during routine root canal treatment. The analysis will be performed using ELISA. The aim is to compare the expression levels between healthy individuals and patients with irreversible pulpitis.

    Time frame: Immediately after the procedure

Secondary outcomes

  1. Correlation analysis between Aquaporin (AQP-4, AQP-5, AQP-9) and IL-8 levels in pulp tissue, dentin fluid, and GCF samples

    The study will assess the correlation between Aquaporin isoforms (AQP-4, AQP-5, and AQP-9) and IL-8 concentrations within and between two groups: healthy individuals and patients diagnosed with irreversible pulpitis. Correlation analyses will be conducted separately for each group, as well as comparatively across groups, using appropriate statistical methods to explore intra- and intergroup relationships among biomarkers in pulp tissue, dentin fluid, and GCF samples.

    Time frame: Immediately after the procedure

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06938191
Responsible party
Ali Erdemir (Professor doctor, Kırıkkale University) — Principal investigator
First posted
Apr 22, 2025
Start date
Dec 2025 (estimated)
Primary completion
Feb 2026 (estimated)
Completion
Sep 12, 2026 (estimated)
Last update
Dec 1, 2025

Study contacts

ALİ ERDEMİR, PROF.
Contact
erdemirali@hotmail.com
+905325650065
TANSU M BEŞPARMAK
Contact
tansumervebesparmak@gmail.com
+905398973940
TANSU M BEŞPARMAK, PhD student
principal investigator · Kirikkale University, Faculty of Dentistry
ALİ ERDEMİR, PROF
study chair · Kirikkale University, Faculty of Dentistry

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion